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Abstract
Chagas disease is a parasitic disorder caused by the infection with the flagellated protozoan
Trypanosoma cruzi. According to the World Health Organization, more than six million peo-
ple are currently infected in endemic regions. Genetic factors have been proposed to influ-
ence predisposition to infection and development of severe clinical phenotypes like chronic
Chagas cardiomyopathy (CCC). Interleukin 18 (IL18) encodes a proinflammatory cytokine
that has been proposed to be involved in controlling T. cruzi infection. In this study, we ana-
lyzed the possible role of six IL18 gene variants (rs5744258, rs360722, rs2043055,
rs187238, rs1946518 and rs360719), which cover most of the variation within the locus, in
the susceptibility to infection by T. cruzi and/or CCC. In total, 1,171 individuals from a
Colombian region endemic for Chagas disease, classified as seronegative (n = 595), sero-
positive asymptomatic (n = 175) and CCC (n = 401), were genotyped using TaqMan probes.
Significant associations with T. cruzi infection were observed when comparing seronegative
and seropositive individuals for rs187238 (P = 2.18E-03, OR = 0.77), rs360719 (P = 1.49E-
03, OR = 0.76), rs2043055 (P = 2.52E-03, OR = 1.29), and rs1946518 (P = 0.0162, OR =
1.22). However, dependence analyses suggested that the association was mainly driven by
the polymorphism rs360719. This variant is located within the promoter region of the IL18
gene, and it has been described that it creates a binding site for the transcription factor
OCT-1 affecting IL-18 expression levels. In addition, no evidence of association was
observed between any of the analyzed IL18 gene polymorphisms and the development of
CCC. In summary, our data suggest that genetic variation within the promoter region of IL18
is directly involved in the susceptibility to infection by T. cruzi, which provides novel insight
into disease pathophysiology and adds new perspectives to achieve a more effective dis-
ease control.
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Author Summary
Chagas disease is a parasitic disorder caused by the infection with the protozoan Trypano-
soma cruzi. In Latin America, this disease represents a major public health concern, as
almost 6 million people are currently infected. During the last years, great efforts have
been made in health policy to control the disease; however, there is still a long way ahead
to achieve this challenging goal. Most affected people remains asymptomatic after infec-
tion for the rest of their lives, but around one third of infected people may develop cardio-
myopathy, a condition that reduces dramatically the quality of life and life expectancy in
Chagas patients. The causes of the marked differential disease outcomes are currently
unknown, but it is believed that a genetic predisposition could play a relevant role in the
host. We investigated in an endemic region of Colombia whether the IL18 gene, which is
involved in the immune response to intracellular pathogens like T. cruzi, is related to a
higher susceptibility to infection or disease severity. Our results suggest that IL18 is a rele-
vant gene in Chagas disease, and could represent a valuable insight that may help to better
understand the disease pathogenesis and the development of more efficient therapeutic
strategies.
Introduction
Host genetic factors have been suggested to play an important role in the susceptibility to
human infectious diseases [1]. An example of such conditions is Chagas disease, which is
caused by infection of the protozoan Trypanosoma cruzi. Recent estimations indicate that
more than 70 million people live in endemic areas for this parasite, with around 6 million peo-
ple being currently infected and a reported incidence of the disease of almost 30,000 cases
[2,3]. Two phases, acute and chronic, are clearly defined in Chagas disease. The early stages are
characterized by acute symptoms like fever, headache or swollen lymph nodes. After 8–12
weeks from the bite, infected individuals enter the chronic phase of the disease, in which most
of them will remain asymptomatic for the rest of their lives. However, around 30% of patients
will develop further symptoms, including chronic cardiomyopathy and/or digestive complica-
tions [4]. During the last decade, several studies have investigated the possible role of gene
polymorphisms in the predisposition to T. cruzi infection and/or chronic Chagas cardiomyop-
athy in patients from endemic countries, reporting promising results [5–17].
Interleukin 18 (IL18) is one of the genes that have been proposed to influence the develop-
ment of Chagas disease. It encodes a proinflammatory cytokine that was originally described as
an interferon-gamma (IFN-γ) inducing factor. Because of this, IL-18 was classified among the
Th1-inducing family of cytokines, along with IL-2, IL-12 and IL-15 [18]. Due to its crucial role
in the induction of IFN-γ production by T cells and NK cells, thus promoting the Th1
response, IL-18 is considered a relevant molecule for controlling intracellular pathogens
[19,20].
In Chagas disease, IFN-γ is essential for parasite control during the early stages of the infec-
tion. It has been described that knockout mice for IFNG are highly susceptible to infection due
to defective macrophage activation and nitric oxide production [21]. Interestingly, mice inocu-
lated with T. cruzi displayed elevated IL-18 levels 6 days after infection followed by an increase
of IL-12 and IFNγ [22]. Indeed, IL-18 can mediate IFN-γ induction in T cells in an IL-12 inde-
pendent manner [23].
Consistent with the above, previous studies have suggested a genetic influence of both IFNG
and IL18 gene variants in the susceptibility to infection by T. cruzi and Chagas cardiomyopathy,
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respectively [9,15], adding additional evidences to the high relevance that this pathway may
have in Chagas disease development.
Taking into consideration all this knowledge, we decided to perform a comprehensive anal-
ysis of the IL18 variation, in a well-powered cohort from an endemic region of T. cruzi, in
order to dissect the possible genetic association of the region with predisposition to infection
by this parasite and/or the development of cardiomyopathy in Chagas patients.
Materials and Methods
Study subjects
A total of 1,171 Colombian individuals from an endemic region for Chagas disease (Guanen-
tina and Comunera provinces, at the department of Santander localized between 5°26’ and 8°
08’ north and 72°26’ and 74°32’ west) were included in this study (S1 Fig). The population in
this region of Colombia is a homogeneous mixture, with no specific concentration of any eth-
nicity. All participants underwent a serological diagnosis for T. cruzi infection by means of the
enzyme-linked immunosorbent assay (ELISA) and a commercial indirect hemagglutination
test. According to the results of these tests, 576 individuals were classified as seropositive for T.
cruzi antigens and 595 were classified as seronegative, with this latter group being used as con-
trols. Subsequently, and based on the results of the clinical evaluation, an electrocardiogram
and echocardiogram were recorded to detect any conduction alteration and/or structural car-
diomyopathy. As a result, 175 seropositive individuals were classified as asymptomatic and 401
individuals were classified as having chronic Chagas cardiomyopathy. From this last group,
Chagas patients were further subclassified accordingly to the severity of cardiomyopathy as fol-
lows: CII (n = 166, radiology indicative of light heart hypertrophy or minor ECG alterations),
CIII (n = 200, moderate heart hypertrophy and considerable ECG alterations, mainly conduc-
tion abnormalities) and CIV (n = 35, severe cardiomegaly and marked ECG alterations, pre-
dominantly frequent and/or complex forms of ventricular arrhythmia). The mean age of
participants was 45.86 years for seronegative individuals, 58.00 for asymptomatic individuals
and 63.14 for chronic Chagas cardiomyopathy patients. The sex distribution for the entire
group was 55% female and 45% male. None of the patients included in this study received any
treatment (i.e. Benznidazole) for the infection.
Ethics statement
The Ethics Committees from the ‘Universidad Industrial de Santander and Fundación Cardio-
vascular de Colombia’ approved this study (entitled “Identificación de factores de riesgo genético
para Cardiopatia Chagásica crónica” [Identification of genetic risk factors for chronic Chagas
cardiomyopathy] and approved on June 27th 2005 in the Act No. 15 of 2005) in accordance
with the ethical standards laid down in the 1964 Declaration of Helsinki. Written informed
consent was obtained from all subjects prior to participation.
SNP selection and genotyping
In order to comprehensively analyze the possible role of IL18 on the genetic susceptibility to
Chagas disease, a total of six single-nucleotide polymorphisms (SNP) within the locus were
selected for genotyping following a combined candidate gene/tagging strategy. These include:
1) two promoter variants (rs187238 and rs1946518) that have been reported to affect gene
expression [24–27]; 2) one intronic variant (rs2043055) previously implicated in Chagas dis-
ease outcome in a Brazilian population [15]; 3) an additional promoter variant (rs360719) that
has been described to interact with the transcription factor OCT-1 [28]; and 4) two intronic tag
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SNPs (rs5744258 and rs360722) covering the remaining variability of the IL18 gene. These lat-
ter variants were selected with the software Haploview V4.2 [29] on the basis of both pairwise
tagging (r2>0.80) and minor allele frequencies>0.1, using Colombian-Medellín (CLM) geno-
type data from the 1000 genomes phase III project (http://www.1000genomes.org) [30],
encompassing the coding and promoter regions of IL18 and considering the four previously
selected candidate variants.
Genomic DNA was isolated following standard procedures and the genotyping was per-
formed using TaqMan assays (Applied Biosystems, Foster City, California, USA) on a LightCy-
cler 480 real-time PCR system (Roche Diagnostics, Basel, Switzerland).
Statistical analysis
All statistical analyses were performed with the statistical software package Plink V1.07 (http://
pngu.mgh.harvard.edu/purcell/plink) [31]. Deviance from Hardy-Weinberg equilibrium was
determined at the 1% significance level in all groups of individuals. To test for possible allelic
and genotypic associations, we analyzed the allelic, genotypic and haplotypic frequencies by
comparing seronegative vs. seropositive individuals and asymptomatic vs. chronic Chagas car-
diomyopathy individuals using the χ2 test and logistic regression analyses, when necessary.
The Benjamini & Hochberg step-up false discovery rate (FDR) correction was used in all analy-
ses to control for multiple testing. Permutation tests (10,000 permutations) were also per-
formed in the haplotype analysis to estimate empirical P-values as implemented in Plink. Odds
ratios (OR) and 95% confidence intervals (CI) were calculated according to the Woolf’s
method. P-values lower than 0.05 were considered as statistically significant. Pairwise linkage
disequilibrium (LD) (D’ and r2) and haplotypes were estimated using an expectation–maximi-
zation algorithm implemented in Haploview. In addition, to determine whether the haplotype
model better explained the observed effects than the model considering the individual SNPs,
we compared the goodness of fit of both models by a likelihood ratio test as described elsewhere
[32].
The statistical power of our study (Table A in S1 Text) was estimated with the Power Calcu-
lator for Genetic Studies 2006 (CaTS) software (http://www.sph.umich.edu/csg/abecasis/CaTS/)
[33].
Results
The six IL18 SNPs were in Hardy-Weinberg equilibrium in all the analyzed subgroups
(P>0.01), suggesting that a possible inbreed in Guanentina and Comunera provinces is not
likely. The genotyping success rate was over 95% and the allele frequencies in all cases were
similar to those described for the Colombian population (CLM) of the 1000 genomes phase III
project (http://www.1000genomes.org) [30]. A relatively high LD was observed throughout the
gene in the analyzed population (Fig 1). Particularly, rs187238 and rs360719 showed an r2
value = 0.98, indicating that these two variants are almost completely linked and, consequently,
they may be considered as the same marker for this study.
In order to evaluate the possible association between IL18 gene variants and susceptibility to
T. cruzi infection, the allelic and genotypic frequencies of seronegative and seropositive indi-
viduals were compared (Table 1). The allelic frequencies of four out of the six IL18 genetic vari-
ants were significantly different between these two groups of individuals. In this regard,
rs187238C and rs360719C were significantly increased in seronegative individuals compared
to the seropositive subset (P = 2.18E-03, PFDR = 5.04E-03, OR = 0.77, CI = 0.65–0.91; and
P = 1.49E-03, PFDR = 5.04E-03, OR = 0.76, CI = 0.64–0.90; respectively), thus suggesting that
these variants are associated to protection against infection by T. cruzi. On the contrary, the
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frequencies of rs2043055C and rs1946518C were reduced in the seronegative sample set in
comparison with the seropositive one (P = 2.52E-03, PFDR = 5.04E-03, OR = 1.29, CI = 1.10–
1.53; and P = 0.0162, PFDR = 0.0243, OR1.22, CI = 1.04–1.44; respectively), indicating that they
are associated with a higher infection risk. No statistical significance was observed when the
allelic and genotypic frequencies of both rs5744258 and rs360722 were compared between
seropositive and seronegative individuals.
The marked difference of the average age between the different subgroups of patients (i.e.,
seronegative and seropositive individuals) could represent a limitation in this study, as Chagas
disease is a parasitic disorder in which patients could develop symptoms many years after the
infection [3,4]. To control for this possible confounding factor, we decided to perform a logistic
regression analysis accordingly with the serological status using age as covariate. The statistical
significance was maintained in this analysis thus supporting the consistency of our results
(Table B in S1 Text).
Due to the high LD among the four associated SNPs, which are located either within or
nearby the promoter region, dependency of the associations could be masking a possible
unique causal variant. To check this, conditional logistic regression analyses were conducted
Fig 1. Linkage disequilibrium D’ (A) and R-Squared (B) plots estimated by using expectation-
maximization algorithm in Haploview V4.2. The analysis revealed that IL18 genetic variants were in strong
LD.
doi:10.1371/journal.pntd.0004583.g001
Table 1. Genotype and allele distribution for IL18 polymorphisms in seronegative and seropositive individuals.
Genotype. N (%) Allele test
SNP 1|2 Group (N) 1|1 1|2 2|2 MAF % P P* OR [95% CI]
rs5744258 C|G Seronegative (592) 5 (0.84) 127 (21.45) 460 (77.70) 11.57
Seropositive (570) 2 (0.35) 128 (22.46) 440 (77.19) 11.58 0.9952 0.9952 1.00 [0.78–1.29]
rs360722 T|C Seronegative (591) 7 (1.18) 123 (20.81) 461 (78.00) 11.59
Seropositive (572) 11 (1.92) 119 (20.80) 442 (77.27) 12.33 0.5850 0.7021 1.07 [0.83–1.38]
rs2043055 C|T Seronegative (591) 74 (12.52) 276 (46.70) 241 (40.78) 35.87
Seropositive (568) 98 (17.25) 281 (49.47) 189 (33.27) 41.99 2.52E-03 5.04E-03 1.29 [1.10–1.53]
rs187238 C|G Seronegative (590) 101 (17.12) 276 (46.78) 213 (36.10) 40.51
Seropositive (572) 67 (11.71) 259 (45.28) 246 (43.01) 34.55 2.18E-03 5.04E-03 0.77 [0.65–0.91]
rs1946518 C|A Seronegative (588) 123 (20.92) 309 (52.55) 156 (26.53) 47.19
Seropositive (572) 157 (27.45) 283 (49.48) 132 (23.08) 52.19 0.0162 0.0243 1.22 [1.04–1.44]
rs360719 C|T Seronegative (593) 101 (17.03) 280 (47.22) 212 (35.75) 40.64
Seropositive (572) 67 (11.71) 258 (45.10) 247 (43.18) 34.27 1.49E-03 5.04E-03 0.76 [0.64–0.90]
doi:10.1371/journal.pntd.0004583.t001
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by conditioning each associated SNP to the remaining variants (except for rs187238 that was
almost completely dependent to rs360719). The results of these analyses pointed to rs360719 as
the most likely causative variant of the IL18 association with Chagas disease, as the statistical
significance of both rs2043055 and rs1946518 were clearly lost after conditioning to it, and a
trend was maintained when conditioning rs360719 on these two latter variants (Table 2).
Subsequently, in order to investigate the possible association between IL18 and chronic
Chagas cardiomyopathy, we compared the allelic and genotypic frequencies of the IL18 SNPs
between seropositive asymptomatic individuals and chronic Chagas cardiomyopathy individ-
uals (Table 3). No statistically significant differences were observed between asymptomatic
individuals and chronic Chagasic cardiomyopathy patients for any of the analyzed polymor-
phisms. In addition, to further evaluate the possible association between IL18 and progres-
sion of cardiomyopathy, we compared IL18 allelic and genotypic frequencies by grouping
asymptomatic + CII individuals and CIII + CIV individuals; however, similar to that
observed in the previous analysis, no statistically significant differences were yielded (Table C
in S1 Text).
Finally, we also investigated a possible haplotype effect between the associated SNPs and
susceptibility to T. cruzi infection (Table 4). Five possible haplotypes were observed
(rs2043055|rs187238|rs1946518|rs360719: TCAC, CGCT, TGCT, TGAT and CGAT), with the
haplotypes TCAC and CGCT showing the higher frequencies (37.30% and 37.40%, respec-
tively). In relation to the seronegative vs seropositive analysis, the frequency of TCAC was
increased in the former individuals, being this difference statistically significant (P = 1.50E-03,
PFDR = 7.50E-03, OR = 0.76, CI = 0.65–0.90). On the other hand, the frequency of CGCT was
Table 2. Conditional logistic regression analysis for the IL18 polymorphisms in seronegative and seropositive individuals.
SNP P-value P-value add to rs360719 P-value add to rs2043055 P-value add to rs1946518
rs360719‡ 1.49E-03 NA 0.0996 0.0548
rs2043055 2.52E-03 0.1839 NA 0.1035
rs1946518 0.0162 0.8918 0.6340 NA
‡ Same signal as rs187238
doi:10.1371/journal.pntd.0004583.t002
Table 3. Genotype and allele distribution for IL18 polymorphisms in asymptomatic and chronic Chagas cardiomyopathy (CCC) individuals
Genotype. N (%) Allele test
SNP 1|2 Group (N) 1|1 1|2 2|2 MAF % P OR [95% CI]
rs5744258 C|G Asymptomatic (175) 0 (0.00) 37 (21.14) 138 (78.86) 10.57
CCC (395) 2 (0.51) 91 (23.04) 302 (76.46) 12.03 0.4792 1.16 [0.77–1.73]
rs360722 T|C Asymptomatic (174) 4 (2.30) 29 (16.67) 141 (81.03) 10.63
CCC (398) 7 (1.75) 90 (22.56) 301 (75.69) 13.07 0.2409 1.26 [0.85–1.88]
rs2043055 C|T Asymptomatic (173) 36 (20.81) 78 (45.09) 59 (34.10) 43.35
CCC (395) 62 (15.70) 203 (51.39) 130 (32.91) 41.39 0.5378 0.92 [0.71–1.19]
rs187238 C|G Asymptomatic (173) 25 (14.45) 74 (42.77) 74 (42.77) 35.84
CCC (399) 42 (10.53) 185 (46.37) 172 (43.11) 33.71 0.4862 0.91 [0.70–1.19]
rs1946518 A|C Asymptomatic (175) 45 (25.71) 80 (45.71) 50 (28.57) 48.57
CCC (397) 87 (21.91) 203 (51.13) 107 (26.95) 47.48 0.7337 0.96 [0.74–1.23]
rs360719 C|T Asymptomatic (174) 26 (14.94) 75 (43.10) 73 (41.95) 36.49
CCC (398) 41 (10.30) 183 (45.98) 174 (43.72) 33.29 0.2937 0.87 [0.67–1.13]
doi:10.1371/journal.pntd.0004583.t003
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significantly lower in seronegative individuals compared with seropositive individuals
(P = 0.0116, PFDR = 0.0290, OR = 1.25, CI = 1.05–1.47), whereas the frequencies of TGCT,
TGAT, and CGAT did not differed significantly between seropositive and seronegative individ-
uals. Similar results were observed when the haplotype analysis was performed using permuta-
tion test with 10,000 permutations instead of Chi-square (Table 4). However, the haplotype
model did not better explain the IL18 association to risk of infection than the model consider-
ing the SNPs independently (likelihood P-value = 0.1454), indicating no additive effects (that
is, the associated haplotypes were a consequence of the independent associations of the consid-
ered variants).
In relation to the haplotype analysis according to the presence/absence of chronic Chagas
cardiomyopathy and/or to the progression of cardiomyopathy, no statistically significant dif-
ferences among different subgroups of individuals were observed (Tables D and E in S1 Text).
Discussion
This study evidenced that four genetic variants, namely rs2043055, rs187238, rs1946518 and
rs360719, are statistically associated to differential risk of infection by T. cruzi in a Colombian
population. However, our data suggested that the association is mainly driven by a single SNP,
likely rs360719. Evidences supporting this fact include: 1) this IL18 variant showed the most
significant P-value and the higher effect size; 2) the statistical significance of both rs2043055
and rs1946518 was lost after conditioning on rs360719, whereas a trend towards significance
was clearly observed for rs360719 after conditioning on rs2043055 or rs1946518; 3) no
improvement in the goodness of fit for the model considering the association with rs360719
was observed for any of the haplotypic models; and 4) this IL18 variant has a demonstrated
functional implication in the gene expression [28].
On the other hand, IL18 does not seem to be involved in later parasitic burden in the tissues
of chronic infected patients. It should be noted that the analysis between symptomatic and
asymptomatic patients was performed with lower statistical power than that between seronega-
tive and seropositive patients (S1 Table). Hence, a possible type II error may not be rule out.
Another possibility could be that additional genetic/environmental factors other than this gene
may have a higher relevance for the disease progression [5–7,11–14].
In addition, a lack of association with infection by T. cruzi was observed for rs5744258 and
rs360722. These two polymorphisms had the lower minor allele frequency and, therefore, their
analysis could be limited in terms of statistical power. However, the power considering our study
cohort was not reduced (92% to detect associations with OR = 1.5 at the 5% significance level)
Table 4. IL18 haplotype analysis of seropositive and seronegative individuals.
Seropositive Seronegative
Haplotype N (%) N (%) P *PFDR **PPERM OR [95% CI]
TCAC 391 34.10 479 40.50 1.50E-03 7.50E-03 4.90E-03 0.76 [0.65–0.90]
CGCT 458 40.00 413 35.00 0.0116 0.0290 0.0428 1.25 [1.05–1.47]
TGCT 138 12.10 144 12.20 0.9222 0.9222 1.000 0.99 [0.77–1.27]
TGAT 137 12.00 134 11.30 0.6148 0.7685 0.9758 1.00 [0.89–1.12]
CGAT 18 1.60 12 1.00 0.2262 0.3770 0.6380 1.52 [0.74–3.13]
‡Order of SNPs: rs2043055|rs187238|rs1946518|rs360719
*P value after Benjamini & Hochberg step-up false discovery rate correction.
**Permutation test P-value for 10,000 permutations.
doi:10.1371/journal.pntd.0004583.t004
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and the allele frequencies of the tested groups were very similar (rs5744258: 11.57% vs 11.58%,
OR = 1.00; rs360722: 11.59% vs 12.33%, OR = 1.07). Analysis of larger cohorts would be required
to definitively discard these IL18 variants as susceptibility markers for Chagas disease.
A possible limitation in the inclusion methodology of our study could be that the seronega-
tive group comprised individuals that underwent a seroconversion. However, in our opinion, it
is more likely that seronegative individuals with putative spontaneous cure avoided antibody
production due to a quick innate immune response by killer cells and macrophages instead. No
consistent seroconversion rates have been reported in Chagas patients so far, and serocon-
verted individuals were reported only after treatment when there is not persistence in the infec-
tion [34–36]. None of the seronegative individuals included in our study were either reported
to have Chagas disease or to have a previous therapy.
In addition, it should be noted that there is a considerable high prevalence of cardiac
patients in our study cohort, which could suggest that the seropositive population is biased to
the patients with Chagas cardiomyopathy. However, we would like to state that the participants
were recruited after a medical visit to the endemic area. In this regard, individuals coming to
the citation underwent serological analyses, and those showing seropositivity were subse-
quently subjected to electrocardiograms and further medical analyses in which they were classi-
fied as asymptomatic seropositive or CCC patients. In any case, this sample set has been used
in previously published studies by our group [13] and we are confident about its homogeneity.
IL-18 is a cytokine which induces IFN-γ production activating several immune cells in
response to intracellular pathogens, including T. cruzi [20]. IL-18 was shown to play an impor-
tant role in early immunity to Chagas disease [22,23]. Moreover, the susceptibility to T. cruzi
depends on the capability of releasing IFN-γ during early stages of infection and this is directly
related to release of IL-18 during this phase [37]. Regarding this, it has been reported that
rs360719 may be located within a repressor site of the gene, and individuals carrying the C
allele showed a higher IL18 expression due to the creation of a binding site for the transcription
factor OCT-1 [28]. This is consistent with the protective role that we observed for this allele in
Chagas disease development, and support the hypothesis that major IL-18 levels could increase
parasite clearance in early stages of infection. Besides, our results are also in concordance with
a previous study performed by our group reporting an association between IFNG and suscepti-
bility to infection by T. cruzi [9]. Altogether, these findings clearly point to IL-18 along with
IFN-γ as crucial players in the immune response against infection by this parasite. In any case,
additional functional analyses are needed to confirm this assumption, and to have an accurate
estimation of the putative IL-18 and IFN-γ levels that may discriminate the different subgroups
of Chagas patients from each other and from the healthy population.
On the other hand, a previous study showed that IL18 rs2043055 may modulate Chagas dis-
ease severity in a Brazilian population [15]. In our study we were not able to find an association
of any of the analyzed IL18 SNPs (including this one) with the severity of Chagas disease. We
speculate that the discrepancy could be due to a different genetic background between the ana-
lyzed cohorts from Brazil and Colombia. Despite being both populations a mixture from
Amerindian, west-European and African populations, the proportion of these ancestries could
differ between them, which would affect the LD and haplotypic block architecture across the
genome [38–40]. It would be interesting, therefore, to examine whether the association
described for rs2043055 is dependent upon rs360719 in the Brazilian population, as our data
suggest based on the LD structure observed in our Colombian cohort. In any case, both studies
open a new window to understand differences in Chagas disease outcome and susceptibility.
Another explanation for the observed differences between both studies could be the existence
of different T. cruzi strains in the studied regions from Colombia and Brazil, as the two strains
present in such areas (I and II, respectively) have been described to be implicated in CCC
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development and severity [41]. The analysis of the specific strains affecting both our popula-
tion and the Brazilian one was out of the scope of this study, but it could represent an interest-
ing future complementary analysis to this reported here.
The influence of IL18 gene variants on the susceptibility to infection or severity of other pro-
tozoan infectious diseases has been also evaluated. In this context, a weak association between
the IL18 SNP rs1946519, and a higher risk to develop Leishmaniasis was described in Iranians
[42]. Nevertheless, the authors did not find evidence of association between Leishmania infec-
tion and rs187238, which was associated with T. cruzi infection in our study. As stated before,
the discrepancy could be due to population-specific genetic architectures within the gene, but
also to the fact that our study had a considerably higher statistical power.
Additionally, the possible role of the IL18 gene variants rs187238 and rs1946518 in severe
malaria anemia and mortality were also investigated in a Kenyan children population [43]. The
authors of that study observed that homozygosity for the rs1946518A allele conferred protec-
tion against severe malaria, and that the allelic combination of rs187238G and rs19463518C
had a higher frequency in the severe malaria group compared to the non-severe group [43]. In
our study, the frequency of the AA genotype for rs1946518 was increased in asymptomatic
individuals compared to chronic Chagas cardiomyopathy patients, but this difference was not
statistically significant. Similarly, the frequency of the rs187238G|rs19463518C haplotype
was increased in chronic cardiomyopathy individuals compared with asymptomatic patients,
although the difference did not reach statistical significance either. Additional studies encom-
passing larger cohorts of seropositive patients with different degrees of disease severity may
shed light into these putative associations.
IL18 gene variants have also been evaluated in other infectious conditions such as hepatitis
B or C viruses. Cumulating data indicate that IL-18 may influence the clearing of the viral load
[44–46], as well as the severity of the infection in some cases of hepatic carcinomas or cirrhosis
[26,47,48]. In this context, it has been proposed that differential expression levels of IL18 could
be directly involved in the predisposition to infection by the above mentioned viruses and in
the severity of hepatitis [26,44–48], consistent with what we observed in Chagasic patients.
In conclusion, our results suggest that IL18 variation plays an important role in the suscepti-
bility to infection by T. cruzi, probably by influencing IL-18 production during the immune
response in the early stages of the infection. The promoter polymorphism rs360719 is likely the
causal variant of this association, at least in the Colombian population. In any case, further
studies on this gene on different ancestries and larger samples sizes, as well functional analyses,
would be desirable to validate our findings.
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